Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikas Goyal

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Lancet. Respiratory Medicine|May 28, 2021
Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trialTom J C Ruffles, Vikas Goyal, Julie M Marchant, et al.
Trials|April 12, 2022
Bronchiectasis - Exercise as Therapy (BREATH): rationale and study protocol for a multi-center randomized controlled trialTaryn Jones, Kerry-Ann F O'Grady, Vikas Goyal, et al.
BMJ Open Respiratory Research|February 5, 2026
Improving the management and outcomes of preschool wheeze: protocol of a prospective multicentre cohort studyAnne B Chang, Stephanie T Yerkovich, Steven McPhail, et al.
Lancet (London, England)|September 23, 2018
Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trialVikas Goyal, Keith Grimwood, Catherine A Byrnes, et al.
Human Vaccines & Immunotherapeutics|June 27, 2018
The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: A multi-centre, double-blind, randomised controlled trialKerry-Ann F O'Grady, Anne B Chang, Allan Cripps, et al.
ERJ Open Research|March 18, 2026
Improving asthma control assessment and outcomes in children with asthma using an artificial intelligence digital tool: a prospective multicentre cohort studyAnne B Chang, Stephanie T Yerkovich, Steven M McPhail, et al.
The Lancet. Respiratory Medicine|August 21, 2019
Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trialVikas Goyal, Keith Grimwood, Robert S Ware, et al.
ERJ Open Research|July 22, 2021
Clinical and research priorities for children and young people with bronchiectasis: an international roadmapAnne B Chang, Jeanette Boyd, Leanne Bell, et al.
The European Respiratory Journal|June 21, 2022
European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trialsAnne B Chang, Angela Zacharasiewicz, Vikas Goyal, et al.
BMJ Open Respiratory Research|May 8, 2024
Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trialAnne B Chang, Stephanie T Yerkovich, Katherine J Baines, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Lancet. Respiratory Medicine|May 28, 2021
Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trialTom J C Ruffles, Vikas Goyal, Julie M Marchant, et al.
Trials|April 12, 2022
Bronchiectasis - Exercise as Therapy (BREATH): rationale and study protocol for a multi-center randomized controlled trialTaryn Jones, Kerry-Ann F O'Grady, Vikas Goyal, et al.
BMJ Open Respiratory Research|February 5, 2026
Improving the management and outcomes of preschool wheeze: protocol of a prospective multicentre cohort studyAnne B Chang, Stephanie T Yerkovich, Steven McPhail, et al.
Lancet (London, England)|September 23, 2018
Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trialVikas Goyal, Keith Grimwood, Catherine A Byrnes, et al.
Human Vaccines & Immunotherapeutics|June 27, 2018
The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: A multi-centre, double-blind, randomised controlled trialKerry-Ann F O'Grady, Anne B Chang, Allan Cripps, et al.
ERJ Open Research|March 18, 2026
Improving asthma control assessment and outcomes in children with asthma using an artificial intelligence digital tool: a prospective multicentre cohort studyAnne B Chang, Stephanie T Yerkovich, Steven M McPhail, et al.
The Lancet. Respiratory Medicine|August 21, 2019
Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trialVikas Goyal, Keith Grimwood, Robert S Ware, et al.
ERJ Open Research|July 22, 2021
Clinical and research priorities for children and young people with bronchiectasis: an international roadmapAnne B Chang, Jeanette Boyd, Leanne Bell, et al.
The European Respiratory Journal|June 21, 2022
European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trialsAnne B Chang, Angela Zacharasiewicz, Vikas Goyal, et al.
BMJ Open Respiratory Research|May 8, 2024
Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trialAnne B Chang, Stephanie T Yerkovich, Katherine J Baines, et al.
Pageof 7